Skip to content

Effects of Strength Exercise on Fall Risk in Elderly With Alzheimer's Disease

Effects of Strength Exercise on Fall Risk in Elderly With Alzheimer's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04981587
Enrollment
64
Registered
2021-07-29
Start date
2021-05-01
Completion date
2022-03-04
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Dementia; Alzheimer's Type (Etiology), Fall Risk, Elderly, Resistance Training

Keywords

alzheimer disease, elderly, exercise, fall risk

Brief summary

Interventional study to show the effects of strength exercise on fall risk in elderly with Alzheimer's disease

Interventions

Strength exercise protocol for upper and lower limbs, using weights and elastic bands

OTHERUsual treatment

The usual treatment is based on activities to enhance brain functions: attention, memory, executive functions, language and orientation.

Sponsors

University of Jaén
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* accept to participate in the study, through informed consent * subjects aged 60 or over with medical diagnosis of Azlheimer´s disease * minimal physical and mental state to perform the cognitive tests and strength exercise routine

Exclusion criteria

* Neurodegenerative disease other than Alzheimer's disease * Suffering from serious somatic or psychiatric illnesses * Patients who have practiced strength exercise regularly

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Short physical performance battery (SPPB) at 3 and 6 monthsBaseline, 3 and 6 months (3 months after intervention)Informs about fall risk and mobility Score: 0-12 High score means better result

Secondary

MeasureTime frameDescription
Change from baseline Lawton Instrumental Activities of Daily Living Scale (IADL) at 3 and 6 monthsBaseline, 3 and 6 months (3 months after intervention)This tool gives us information about performance in activities of daily living Score: 0-8 High score means better result
Change from baseline Quality of life Alzheimer Disease (QoL-AD) at 3 and 6 monthsBaseline, 3 and 6 months (3 months after intervention)Through this test we can know the level of quality of life of users who suffer from this disease Score: 0-52 High score means better result
Change from baseline FRAIL test at 3 and 6 monthsBaseline, 3 and 6 months (3 months after intervention)This rapid test allows to determine the state of frailty of older people Score: 0-5 High score means worst result
Change from baseline Mini Mental State Examination (MMSE) at 3 and 6 monthsBaseline, 3 and 6 months (3 months after intervention)This test gives us information about the cognitive performance of the participants Score: 0-30 High score means better result
Change from baseline Activities specific balance confidence scale (ABC scale) at 3 and 6 monthsBaseline, 3 and 6 months (3 months after intervention)This questionnaire allows to measure the balance of a person Score: 0-100% High percentage means better result
Change from baseline Manual dynamometry at 1,2,3 and 6 monthsBaseline, 1, 2, 3 and 6 months (3 months after intervention)This test allows to quantify force an individual presents in a simple way Score: 0-∞ High score means better result
Modified Borg scale3 times/week during strength exercises sessionsIn this way we can measure the level of perceived exertion during the intervention with strength exercise Score: 0-10 High score means more fatigue
Change from baseline One Maximum repetition strength test (1 MR) at 1,2,3 and 6 monthsBaseline, 1 , 2 , 3 and 6 months (3 months after intervention)Allows you easily to assess maximum strength Score: 0-∞ High score means more strength level
Change from baseline Neuropsychiatric Inventory (NPI-Q) at 3 and 6 monthsBaseline, 3 and 6 months (3 months after intervention)This tool allows to specify the neuropsychiatric symptoms patients present Score: 0-36 High score means worst result

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026